SDI Group Share News (SDI)

LONDON (Dow Jones)--Scientific Digital Imaging PLC (SDI.LN), the AIM quoted group focused on the needs of the scientific community, said Monday ProtoCOL2 has been upgraded to allow rapid statistical analysis of flu and bacterial vaccine potency and antibiotics susceptibility testing results. MAIN FACTS: -Synbiosis technical team found that by using the ProtoCOL2 system, 600 Legionella plates could be accurately processed per hour, which is 30 times more than can be achieved using traditional techniques. -ProtoCOL2 automated colony counter has been extensively tested to enable rapid, accurate counts of Legionella on any Legionella detection media. -Synbiosis has introduced ProcUV, a new UV imaging accessory for the ProtoCOL2 system; ProcUV permits instant imaging of fluorescent colonies and plaques so that they can be automatically counted or analyzed by ProtoCOL2, thus saving time and improving accuracy of results. -Company continues to look at new and innovative ways to improve product offering to meet the needs of the scientific community. -Shares closed Friday at 21.5 pence valuing the company at GBP3.87 million. -By Ian Walker, Dow Jones Newswires; 44-20-7842-9296; ian.walker@dowjones.com (END) Dow Jones Newswires June 28, 2010 02:48 ET (06:48 GMT)